This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Dishman Carbogen Amcis Limited has informed the Exchange regarding Board meeting held on November 04, 2025.
DCAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 8.3 pts less than Nifty Microcap 250 and 8.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board approved unaudited financial results for Q2 and H1 FY26 (ended September 30, 2025). On a consolidated basis, Q2 revenue from operations was Rs 652.65 crores, down from Rs 789.04 crores in Q2 FY25, while H1 revenue grew modestly to Rs 1,360.70 crores from Rs 1,312.82 crores. Net profit after tax jumped to Rs 65.27 crores in Q2 (vs Rs 33.09 crores YoY), and H1 swung to a Rs 88.68 crore profit from a Rs 44.48 crore loss in H1 FY25, aided by lower exceptional items and a sharp improvement in operating margin to 22.81%. On a standalone basis, the company reported a Q2 net loss of Rs 13.61 crores and H1 loss of Rs 10.93 crores, with standalone revenue declining about 35% YoY. The auditors (T R Chadha & Co LLP) issued an unmodified limited review report, with an emphasis-of-matter note on the 99-year goodwill amortization treatment.
Strong consolidated profit recovery and margin expansion are positive signals for shareholders, though weak standalone performance and a YoY decline in consolidated Q2 revenue temper the outlook. The unusual 99-year goodwill amortization assumption remains a point investors should monitor.
| Q2 FY26 | Q2 FY25 | Change | |
|---|---|---|---|
| Revenue | ₹652.7 Cr | ₹789.0 Cr | −17.3% |
| Operating profit | ₹22.43 Cr | ₹38.43 Cr | −41.6% |
| Profit after tax | ₹65.27 Cr | ₹33.09 Cr | +97.2% |
| EBITDA margin | 22.8% | 18.3% | +4.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.